Drug Trial Radar · NCT03334435
A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis
Last checked: Nov 20, 2026Latest source record: Sep 3, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,645
Actual
Start
Mar 28, 2018
Primary completion
Sep 21, 2020
Study completion Jul 12, 2023
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- Collaborators
- Incyte Corporation
- First posted
- Nov 7, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the long-term safety and efficacy of baricitinib in participants with atopic dermatitis. Participants were enrolled in this study from the originating studies (JAHL, JAHM, JAIY) or were directly enrolled in the open-label arm.
Conditions
- Atopic Dermatitis
Interventions
BaricitinibDrug
Administered orally
PlaceboDrug
Administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Responder and Partial Responders (RPR): Percentage of Participants From Monotherapy Studies (JAHL, JAHM) Who Achieved a Response of Investigator's Global Assessment (IGA) 0 or 1Time frame: Weeks 16, 36 and 52
- RPR: Percentage of Participants From Combination Therapy Study (JAIY) Who Achieved a Response of IGA 0 or 1Time frame: Weeks 16, 36, and 52
Locations
185 sites in 19 countries. Site status is shown where the registry gives one.
Centro de Investigaciones Metabólicas (CINME)
Buenos Aires, Argentina
Buenos Aires Skin
Ciudad Autonoma Buenos Aires, Argentina
Fundacion CIDEA
Ciudad Autonoma Buenos Aires, Argentina
Instituto de Neumonología y Dermatología
Ciudad Autonoma Buenos Aires, Argentina
Psoriahue Medicina Interdisciplinaria
Ciudad Autonoma Buenos Aires, Argentina
Parra Dermatología
Mendoza, Argentina
CEDIC-Centro de Investigaciones Clinicas
Caba, Buenos Aires, Argentina
Woden Dermatology
Phillip, Australian Capital Territory, Australia
Skin & Cancer Foundation Australia
Westmead, New South Wales, Australia
The Skin Centre
Benowa, Queensland, Australia
Veracity Clinical Research Pty Ltd
Woolloongabba, Queensland, Australia
Clinical Trials SA Pty Ltd
Adelaide, South Australia, Australia
Skin and Cancer Foundation Inc.
Carlton, Victoria, Australia
Fremantle Dermatology
Perth, Western Australia, Australia
KA Rudolfstiftung
Vienna, Austria
AKH
Vienna, Austria
KH Hietzing mit neurologischem Zentrum Rosenhügel
Vienna, Austria
Sozialmed. Zentrum Ost - Donauspital
Vienna, Austria
Universitätsklinikum Graz
Graz, Styria, Austria
Ordensklinikum Linz GmbH - Elisabethinen
Linz, Upper Austria, Austria
Kozni ambulance Kutna Hora, s.r.o.
Kutná Hora, Central Bohemia, Czechia
Clintrial, s.r.o.
Prague, Hl. M. Praha, Czechia
Fakultni nemocnice Kralovske Vinohrady
Prague, Hl. M. Praha, Czechia
Fakultni Nemocnice v Motole
Prague, Hl. M. Praha, Czechia
Nemocnice Na Bulovce
Prague, Hl. M. Praha, Czechia
Nemocnice Novy Jicin a.s.
Nový Jičín, Moravian-Silesian Region, Czechia
Fakultni Nemocnice Plzen
Plzen-Bory, Plzeň Region, Czechia
Fakultni Nemocnice U svate Anny
Brno, South Moravian, Czechia
Krajska zdravotni a.s. - Masarykova nemocnice v Usti nad Labem, o.z.
Ústí nad Labem, Ustecký Kraj, Czechia
Gentofte Hospital
Hellerup, Capital Region, Denmark
Aarhus Universitehospital Marselisborg Centret
Aarhus, Region Midtjyland, Denmark
CHU de Bordeaux Hopital Saint Andre
Bordeaux, France
CHU Grenoble Alpes
Grenoble Cédex 9, France
Chru De Nantes Hotel-Dieu
Nantes, France
CHU de Nice Hopital de L'Archet
Nice, France
Centre Hospitalier Lyon Sud
Pierre-Bénite, France
Hopital Larrey
Toulouse, France
Hopital Saint-Louis
Paris, Cedex 10, France
Universitätsklinikum Aachen AöR - Klinik für Dermatologie und Allergologie - Hautklinik
Aachen, Germany
Charité Universitätsmedizin Berlin
Berlin, Germany
Showing 40 of 185 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.